NO20052928L - Nye kjemiske forbindelser - Google Patents

Nye kjemiske forbindelser

Info

Publication number: NO20052928L
Authority: NO; Norway
Prior art keywords: chemical compounds; new chemical; hyak3 proteins; imbalance; proteins
Prior art date: 2002-11-22

Application number

NO20052928A

Other languages

English (en)

Norwegian (no)

Other versions

NO20052928D0 (no

Inventor

Jun Tang

Hideyuki Sato

Masaichi Hasegawa

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-22

Filing date

2005-06-15

Publication date

2005-08-17

2005-06-15 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2005-06-15 Publication of NO20052928D0 publication Critical patent/NO20052928D0/no

2005-08-17 Publication of NO20052928L publication Critical patent/NO20052928L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20052928A 2002-11-22 2005-06-15 Nye kjemiske forbindelser NO20052928L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US42838402P	2002-11-22	2002-11-22
PCT/US2003/037658 WO2004047760A2 (fr)	2002-11-22	2003-11-18	Nouveaux composes chimiques

Publications (2)

Publication Number	Publication Date
NO20052928D0 NO20052928D0 (no)	2005-06-15
NO20052928L true NO20052928L (no)	2005-08-17

Family

ID=32393394

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052928A NO20052928L (no)	2002-11-22	2005-06-15	Nye kjemiske forbindelser

Country Status (30)

Country	Link
US (1)	US7767701B2 (fr)
EP (1)	EP1567112B1 (fr)
JP (1)	JP2006509765A (fr)
KR (1)	KR20050085115A (fr)
CN (1)	CN100579978C (fr)
AP (1)	AP1967A (fr)
AR (1)	AR045407A1 (fr)
AT (1)	ATE411302T1 (fr)
AU (1)	AU2003298693B2 (fr)
BR (1)	BR0316502A (fr)
CA (1)	CA2507256A1 (fr)
CY (1)	CY1108655T1 (fr)
DE (1)	DE60324178D1 (fr)
DK (1)	DK1567112T3 (fr)
EA (1)	EA008865B1 (fr)
EC (1)	ECSP055808A (fr)
ES (1)	ES2315566T3 (fr)
IS (1)	IS2659B (fr)
MA (1)	MA27701A1 (fr)
MX (1)	MXPA05005406A (fr)
MY (1)	MY140132A (fr)
NO (1)	NO20052928L (fr)
NZ (1)	NZ539873A (fr)
OA (1)	OA12963A (fr)
PL (1)	PL377564A1 (fr)
PT (1)	PT1567112E (fr)
SI (1)	SI1567112T1 (fr)
TW (1)	TWI309648B (fr)
UA (1)	UA80572C2 (fr)
WO (1)	WO2004047760A2 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4291696B2 (ja)	2002-01-22	2009-07-08	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	２−（ピリジン−２−イルアミノ）−ピリド［２，３−ｄ］ピリミジン−７−オン
JP4053073B2 (ja) *	2003-07-11	2008-02-27	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	選択的ｃｄｋ４阻害剤のイセチオン酸塩
ES2328146T3 (es) *	2003-07-28	2009-11-10	Merck Serono Sa	2-imino-4-(tio)oxo-5-policiclovinilazolinas para su uso como inhibidores de p13 quinasas.
PL1689726T3 (pl)	2003-11-21	2011-05-31	Actelion Pharmaceuticals Ltd	Pochodne 5-(benz-(z)-ylideno)tiazolidyn-4-onu jako środki immunosupresyjne
USRE43833E1 (en)	2003-11-21	2012-11-27	Actelion Pharmaceuticals Ltd.	Thiazolidin-4-one derivatives
WO2005082901A1 (fr) *	2004-02-25	2005-09-09	Smithkline Beecham Corporation	Nouveaux composes chimiques
AR050253A1 (es)	2004-06-24	2006-10-11	Smithkline Beecham Corp	Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
EP1771443B1 (fr) *	2004-07-01	2009-01-07	F.Hoffmann-La Roche Ag	Quinoline thiazolinones avec une activite antiproliferante cdk-1
AU2005259512A1 (en)	2004-07-01	2006-01-12	F. Hoffmann-La Roche Ag	Thiazolinone unsubstituted quinolines
US7241893B2 (en) *	2004-09-17	2007-07-10	Hoffman-La Roche Inc.	Thiazolinone 2-substituted quinolines
US7253285B2 (en)	2004-09-17	2007-08-07	Hoffmann-La Roche Inc.	Thiazolinone 4-monosubstituted quinolines
US20090042773A1 (en) *	2004-10-12	2009-02-12	Reinhard Wetzker	P13 kinase gamma inhibitors for the treatment of anaemia
JP2008516903A (ja) *	2004-10-14	2008-05-22	エフ．ホフマン−ラロシュアーゲー	抗癌剤としての新規アザインドールチアゾリノン
JP2008516905A (ja) *	2004-10-14	2008-05-22	エフ．ホフマン−ラロシュアーゲー	Ｃｄｋ１抗増殖活性を有する１，５−ナフチリジンアゾリジノン
CA2583311A1 (fr)	2004-10-14	2006-04-20	F. Hoffmann-La Roche Ag	Quinazolinylmethylene thiazolinones en tant qu'inhibiteurs de cdk1
US7304074B2 (en) *	2005-04-05	2007-12-04	Hoffmann-La Roche Inc.	Substituted 1,5-naphthyridine azolinones
AR053602A1 (es) *	2005-05-03	2007-05-09	Smithkline Beecham Corp	Compuesto de 2- arilamino -4-oxo-1,3-tiazol-5(4h)- substituido, composicion farmaceutica que lo comprende, proceso para prepararla y uso del compuesto para preparar un medicamento
US20090203692A1 (en) *	2005-05-23	2009-08-13	Smithkline Beecham Corporation	Novel chemical compounds
TW200716580A (en) *	2005-06-08	2007-05-01	Smithkline Beecham Corp	(5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
JP2008543769A (ja) *	2005-06-08	2008-12-04	スミスクライン・ビーチャム・コーポレイション	（５ｚ）−５−（６−キノキサリニルメチリデン）−２−［（２，４，６−トリクロロフェニル）アミノ］−１，３−チアゾール−４（５ｈ）−オン
TW200745066A (en)	2005-09-16	2007-12-16	Torrent Pharmaceuticals Ltd	Novel PTP1B inhibitors
WO2007056683A2 (fr) *	2005-11-08	2007-05-18	Smithkline Beecham Corporation	Nouveaux composés chimiques
EP1993538A4 (fr) *	2006-03-02	2010-05-19	Glaxosmithkline Llc	Thiazolones utilisés en tant qu'inhibiteurs de p13-kinases
US20090023742A1 (en) *	2006-03-02	2009-01-22	Dashyant Dhanak	Thiazolones for use as pi3 kinase inhibitors
KR100752757B1 (ko) *	2006-04-05	2007-08-29	한국과학기술연구원	2-페닐이미노-1,3-티아졸린을 포함하는 미백 조성물
WO2007127212A2 (fr) *	2006-04-25	2007-11-08	The Cleveland Clinic Foundation	Agents anti-viraux qui activent l'arnse l
EP2489662B1 (fr) *	2006-11-23	2014-08-06	Actelion Pharmaceuticals Ltd.	Intermédiaires d'un nouveau procédé pour la préparation de dérivés de 5-benzylidène-2-alkylimino-3-phénylthiazolidin-4-one
US8912340B2 (en)	2006-11-23	2014-12-16	Actelion Pharmaceuticals Ltd.	Process for the preparation of 2-imino-thiazolidin-4-one derivatives
US20100286041A1 (en) *	2007-03-22	2010-11-11	Smithkline Beecham Corporation	(5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
CN101274918A (zh) *	2007-03-30	2008-10-01	中国科学院上海药物研究所	一类取代五元杂环化合物,其制备方法和医学用途
WO2010122979A1 (fr)	2009-04-20	2010-10-28	Ｓｂｉバイオテック株式会社	Dérivé de thiazolidinone
CA2880487C (fr) *	2012-07-30	2018-07-24	Kyoto University	Utilisation d'un compose et d'une composition pharmaceutique pour un trouble neuropsychologique ou une tumeur maligne
HUE050733T2 (hu)	2012-08-17	2021-01-28	Actelion Pharmaceuticals Ltd	Eljárás (2Z,5Z)-5-(3-klór-4-((R)-2,3-dihidroxipropoxi)benzilidén)-2-(pro-pilimino)-3-(O-tolil)tiazolidin-4-on elõállítására és ezen eljárásban alkalmazott köztitermék
RU2521390C1 (ru) *	2013-03-14	2014-06-27	Общество с ограниченной ответственностью "Тиацен"	Производное роданина и средство для профилактики опухолевых заболеваний
CN106660976B (zh) *	2014-05-28	2019-11-26	伯尔尼大学	噻唑烷酮化合物及其在治疗精神或神经障碍和炎症，尤其是神经炎症中的用途
CN104370852B (zh) *	2014-11-26	2016-04-20	山东大学	一种噻唑烷酮类化合物及其在制备治疗铁紊乱相关疾病药物中的应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1548312A (fr)	1967-06-06	1968-12-06
JPS5545648A (en)	1978-09-29	1980-03-31	Teikoku Hormone Mfg Co Ltd	2-formyldibenzazepin derivative and its preparation
HU188852B (en) *	1983-03-16	1986-05-28	Richter Gedeon Vegyeszeti Gyar Rt,Hu	Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
SU1611216A3 (ru) *	1986-12-29	1990-11-30	Пфайзер Инк (Фирма)	Способ получени производных тиазолидиндиона или их фармацевтически приемлемых солей с щелочными металлами
DE3874257T2 (de)	1987-03-11	1993-02-11	Kanegafuchi Chemical Ind	Hydroxystyren-derivate.
JPH0197926A (ja)	1987-10-09	1989-04-17	Idemitsu Kosan Co Ltd	有機非線型光学材料
DD270072A1 (de)	1988-03-14	1989-07-19	Univ Halle Wittenberg	Verfahren zur herstellung von 5-aryliden- hoch 2-thiazolin-4-onen
US5306822A (en)	1988-05-25	1994-04-26	Warner-Lambert Company	Arylmethylenyl derivatives of oxazolidinone
US5145753A (en)	1989-09-12	1992-09-08	Mitsubishi Jukogyo Kabushiki Kaisha	Solid electrolyte fuel cell
US5053420A (en)	1989-10-13	1991-10-01	Pershadsingh Harrihar A	Thiazolidine derivatives for the treatment of hypertension
GB9004483D0 (en)	1990-02-28	1990-04-25	Erba Carlo Spa	New aryl-and heteroarylethenylene derivatives and process for their preparation
US5143928A (en)	1990-03-27	1992-09-01	Warner-Lambert Company	3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
JPH052200A (ja)	1990-09-28	1993-01-08	Toshiba Corp	有機非線形光学材料
WO1992013561A1 (fr) *	1991-02-08	1992-08-20	Pro-Neuron, Inc.	Nucleosides d'oxypurine et leurs congeneres, et derives acyle de ceux-ci, pour ameliorer l'hematopoiese
JP3155050B2 (ja)	1991-02-28	2001-04-09	富士通株式会社	荷電粒子ビームを用いた露光方法
EP0554834B1 (fr)	1992-02-03	1998-06-03	Fuji Photo Film Co., Ltd.	Procédé de dispersion d'un colorant et matériau photographique à l'halogénure d'argent contenant un colorant
JP2835246B2 (ja)	1992-06-02	1998-12-14	富士写真フイルム株式会社	ハロゲン化銀写真感光材料
IL106877A (en)	1992-09-10	1998-03-10	Lilly Co Eli	Rhodanine derivatives for use as medicaments for the treatment of alzheimer's disease
EP0587229B1 (fr)	1992-09-11	2002-05-08	Agfa-Gevaert	Element photographique contenant un colorant-filtre pour applications avec traitement rapide
EP0587230B1 (fr)	1992-09-11	2003-11-26	Agfa-Gevaert	Element photographique contenant un colorant-filtre pour applications avec traitement rapide
JPH06128234A (ja)	1992-10-19	1994-05-10	Fuji Photo Film Co Ltd	不斉炭素原子を有する化合物およびそれからなる非線形光学材料
US5554767A (en)	1993-05-21	1996-09-10	Warner-Lambert Company	Alpha-mercaptoacrylic acid derivatives having calpain inhibitory activity
US6251928B1 (en)	1994-03-16	2001-06-26	Eli Lilly And Company	Treatment of alzheimer's disease employing inhibitors of cathepsin D
JP3871354B2 (ja)	1994-07-29	2007-01-24	株式会社フジモト・コーポレーション	新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体
JPH08109176A (ja)	1994-10-07	1996-04-30	Torii Yakuhin Kk	イソローダニンｎ酢酸誘導体
IL117208A0 (en)	1995-02-23	1996-06-18	Nissan Chemical Ind Ltd	Indole type thiazolidines
PT848004E (pt) *	1995-07-31	2003-07-31	Shionogi & Co	Derivados pirrolidina tendo actividade inibidora da fosfolipase a2
US5618835A (en)	1996-02-01	1997-04-08	The Procter & Gamble Company	Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
JPH09255669A (ja)	1996-03-22	1997-09-30	Hisamitsu Pharmaceut Co Inc	新規なベンジリデン誘導体
US5958957A (en)	1996-04-19	1999-09-28	Novo Nordisk A/S	Modulators of molecules with phosphotyrosine recognition units
UY24886A1 (es)	1997-02-18	2001-08-27	Smithkline Beecham Plc	Tiazolidindiona
US6011031A (en)	1997-05-30	2000-01-04	Dr. Reddy's Research Foundation	Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
US6211209B1 (en) *	1997-08-08	2001-04-03	Warner-Lambert Company	Method of inhibiting connective tissue degradation
AU4005299A (en)	1998-05-19	1999-12-06	Regents Of The University Of California, The	Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
AU6330999A (en)	1998-09-30	2000-04-17	Roche Diagnostics Gmbh	Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
US6221613B1 (en)	1998-12-31	2001-04-24	Synaptic Pharmaceutical Corporation	DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
US6689491B1 (en)	1999-02-08	2004-02-10	Fuji Photo Film Co., Ltd.	Luminescent device material, luminescent device using the same, and amine compound
EP1109808A1 (fr)	1999-07-01	2001-06-27	Geron Corporation	Composes indole substitues et leur utilisation dans le traitement du cancer
JP2001348520A (ja)	2000-04-03	2001-12-18	Fuji Photo Film Co Ltd	メチン化合物、固体微粒子分散物、インクジェット用記録液、およびインクジェット記録方法
WO2002006245A1 (fr)	2000-07-05	2002-01-24	Synaptic Pharmarceutical Corporation	Antagonistes selectifs des recepteurs (mch1) d'hormone-1 de concentration de la melanine et utilisation de ceux-ci
US6410734B1 (en)	2000-07-17	2002-06-25	Wyeth	2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
DE10115227A1 (de)	2001-03-28	2002-12-19	Bayer Ag	Optischer Datenträger enthaltend in der Informationsschicht eine lichtabsorbierende Verbindung mit mehreren chromophoren Zentren
US6452014B1 (en)	2000-12-22	2002-09-17	Geron Corporation	Telomerase inhibitors and methods of their use
TW200304375A (en)	2001-12-06	2003-10-01	Maxia Pharmaceuticals Inc	2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer

2003
- 2003-11-18 WO PCT/US2003/037658 patent/WO2004047760A2/fr not_active Ceased
- 2003-11-18 DE DE60324178T patent/DE60324178D1/de not_active Expired - Lifetime
- 2003-11-18 BR BR0316502-7A patent/BR0316502A/pt not_active IP Right Cessation
- 2003-11-18 EP EP03796448A patent/EP1567112B1/fr not_active Expired - Lifetime
- 2003-11-18 US US10/535,690 patent/US7767701B2/en not_active Expired - Fee Related
- 2003-11-18 SI SI200331463T patent/SI1567112T1/sl unknown
- 2003-11-18 JP JP2004555721A patent/JP2006509765A/ja not_active Ceased
- 2003-11-18 EA EA200500856A patent/EA008865B1/ru not_active IP Right Cessation
- 2003-11-18 OA OA1200500154A patent/OA12963A/en unknown
- 2003-11-18 KR KR1020057009243A patent/KR20050085115A/ko not_active Ceased
- 2003-11-18 DK DK03796448T patent/DK1567112T3/da active
- 2003-11-18 UA UAA200504788A patent/UA80572C2/uk unknown
- 2003-11-18 AU AU2003298693A patent/AU2003298693B2/en not_active Ceased
- 2003-11-18 NZ NZ539873A patent/NZ539873A/en not_active IP Right Cessation
- 2003-11-18 ES ES03796448T patent/ES2315566T3/es not_active Expired - Lifetime
- 2003-11-18 CA CA002507256A patent/CA2507256A1/fr not_active Abandoned
- 2003-11-18 PL PL377564A patent/PL377564A1/pl not_active Application Discontinuation
- 2003-11-18 PT PT03796448T patent/PT1567112E/pt unknown
- 2003-11-18 CN CN200380109119A patent/CN100579978C/zh not_active Expired - Fee Related
- 2003-11-18 AT AT03796448T patent/ATE411302T1/de active
- 2003-11-18 MX MXPA05005406A patent/MXPA05005406A/es active IP Right Grant
- 2003-11-18 AP AP2005003304A patent/AP1967A/xx active
- 2003-11-20 TW TW092132476A patent/TWI309648B/zh not_active IP Right Cessation
- 2003-11-20 MY MYPI20034473A patent/MY140132A/en unknown
- 2003-11-20 AR ARP030104299A patent/AR045407A1/es not_active Application Discontinuation
2005
- 2005-05-20 EC EC2005005808A patent/ECSP055808A/es unknown
- 2005-05-27 MA MA28303A patent/MA27701A1/fr unknown
- 2005-06-02 IS IS7879A patent/IS2659B/is unknown
- 2005-06-15 NO NO20052928A patent/NO20052928L/no not_active Application Discontinuation
2008
- 2008-12-29 CY CY20081101499T patent/CY1108655T1/el unknown

Also Published As

Publication number	Publication date
CY1108655T1 (el)	2014-04-09
TW200418819A (en)	2004-10-01
US20060293338A1 (en)	2006-12-28
MY140132A (en)	2009-11-30
AU2003298693B2 (en)	2010-09-30
NZ539873A (en)	2008-09-26
AR045407A1 (es)	2005-10-26
PL377564A1 (pl)	2006-02-06
EA200500856A1 (ru)	2005-10-27
TWI309648B (en)	2009-05-11
AU2003298693A1 (en)	2004-06-18
ATE411302T1 (de)	2008-10-15
MA27701A1 (fr)	2006-01-02
EA008865B1 (ru)	2007-08-31
OA12963A (en)	2006-10-13
EP1567112B1 (fr)	2008-10-15
BR0316502A (pt)	2005-10-04
MXPA05005406A (es)	2005-08-03
DE60324178D1 (de)	2008-11-27
CN1742010A (zh)	2006-03-01
ES2315566T3 (es)	2009-04-01
JP2006509765A (ja)	2006-03-23
WO2004047760A3 (fr)	2004-10-21
UA80572C2 (en)	2007-10-10
PT1567112E (pt)	2009-01-08
EP1567112A2 (fr)	2005-08-31
AP1967A (en)	2009-03-10
IS2659B (is)	2010-08-15
ECSP055808A (es)	2005-09-20
HK1083443A1 (en)	2006-07-07
AP2005003304A0 (en)	2005-06-30
CN100579978C (zh)	2010-01-13
WO2004047760A2 (fr)	2004-06-10
EP1567112A4 (fr)	2006-11-15
KR20050085115A (ko)	2005-08-29
US7767701B2 (en)	2010-08-03
SI1567112T1 (sl)	2009-02-28
NO20052928D0 (no)	2005-06-15
CA2507256A1 (fr)	2004-06-10
DK1567112T3 (da)	2009-02-09
IS7879A (is)	2005-06-02

Publication	Publication Date	Title
NO20052928L (no)	2005-08-17	Nye kjemiske forbindelser
ATE433973T1 (de)	2009-07-15	Azolylaminoazine als inhibitoren von proteinkinasen
DE602004014117D1 (de)	2008-07-10	Thiazole zur verwendung als inhibitoren von protein-kinasen
EP1575414A4 (fr)	2008-02-20	Methodes et dispositifs de detection et de therapie de plaques atheromateuses
ATE408601T1 (de)	2008-10-15	Fredericamycin-derivate
EA200900802A1 (ru)	2010-04-30	Способы и композиции для лечения амилоидных заболеваний
EA200600078A1 (ru)	2006-08-25	Способы и композиции для лечения амилоидных заболеваний
NO20075815L (no)	2008-01-11	Formuleringer og metoder for behandling av amyloidose
ATE292801T1 (de)	2005-04-15	Verfahren zum screening von inhibitoren von asp2
NO20055741D0 (no)	2005-12-05	Nye kjemiske forbindelser
ATE367380T1 (de)	2007-08-15	Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
ATE421501T1 (de)	2009-02-15	2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
DE60329326D1 (de)	2009-10-29	Tace inhibitoren
ATE549024T1 (de)	2012-03-15	Chinazolin-kaliumkanalhemmer
ATE473728T1 (de)	2010-07-15	Verwendung von fluoreszierenden perlylenverbindungen zur behandlung menschlicher haare
ATE302002T1 (de)	2005-09-15	Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ATE290857T1 (de)	2005-04-15	Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DK1234025T3 (da)	2008-11-17	Humane enzymer fra metalloproteasefamilien
ATE361071T1 (de)	2007-05-15	Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE60213365D1 (de)	2006-09-07	Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
WO2005070042A8 (fr)	2006-08-24	Nouveaux composes chimiques
ATE410235T1 (de)	2008-10-15	Behandlung von ballastwasser
ATE536874T1 (de)	2011-12-15	Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
NO20072048L (no)	2007-05-30	Anvendelse av IL-17F for behandling og/eller forebygging av neurologiske sykdommer.
DE60326348D1 (de)	2009-04-09	Makrozyclen zur behandlung von krebserkrankungen

Legal Events

Date	Code	Title	Description
2012-01-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application